Hepatitis C Diagnosis to Treatment Management - Trial NCT05725109
Access comprehensive clinical trial information for NCT05725109 through Pure Global AI's free database. This phase not specified trial is sponsored by Epividian and is currently Enrolling by invitation. The study focuses on Hepatitis C. Target enrollment is 3500 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Epividian
Timeline & Enrollment
N/A
Jan 09, 2023
Oct 09, 2023
Primary Outcome
Prescriptions for HCV treatment
Summary
The objective of this study is to evaluate whether sending alerts to healthcare providers and
 clinic staff to identify patients with untreated hepatitis C infection can increase the
 uptake of hepatitis C treatment. A period of time without alerts will be compared to a period
 of time with alerts.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05725109
Non-Device Trial